Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years
{{output}}
Importance: Active monitoring of health outcomes after COVID-19 vaccination offers early detection of rare outcomes that may not be identified in prelicensure trials. ... ...
